AdvancedCPR SolutionsTM (ACS), develops and markets solutions to potentially improve survival outcomes from sudden cardiac arrest — the leading cause of death in the US and Europe of adults over 40 years of age, and the third largest cause of death overall (estimated at >470,000/yr. in the US).
Sudden Cardiac Arrest (SCA)
Sudden cardiac arrest, the abrupt loss of heart function that occurs when the heart’s electrical system malfunctions, is a leading cause of death globally, claiming a life every 90 seconds and taking more lives annually than breast cancer, lung cancer and HIV/AIDs combined. 1
Benjamin et al. (2018). Heart Disease and Stroke Statistics — 2018 Update. Circulation, 137, e355-e372. doi:10.1161/CIR.0000000000000558
as Part of a Bundle of Care
ElevatedCPR therapy is a technologically-advanced method of performing device-assisted head up CPR that incorporates lifting the head, heart, and thorax in a multi-angled incline, in a timed sequence, in conjunction with best practice resuscitation protocols. ElevatedCPR therapy is intended to be used with a bundle of care, including active compression-decompression and/or mechanical CPR devices and an impedance threshold device (ITD), to help regulate the intrathoracic pressure while CPR is being performed.
Founded in Minneapolis, MN as Minnesota Resuscitation Solutions in 2015, AdvancedCPR Solutions is the pioneer of ElevatedCPR therapy, a broad, patent-protected evidence-based resuscitation therapy centered on patient positioning that could potentially improve survival from sudden cardiac arrest. Our early stage medical device firm is focused on the development and commercialization of ElevatedCPR therapy delivery mechanisms, methods, and devices.
The Science Behind ElevatedCPRTM Therapy
ElevatedCPR therapy, or device-assisted head up CPR, is a method for performing cardiopulmonary resuscitation (CPR) that incorporates lifting the head, heart, and thorax in a multi-angled incline, in a timed sequence. This positioning allows the body to drain venous blood from the brain while CPR is being performed; and pre-clinical evidence shows a number of benefits associated with this positioning relative to intracranial pressure (ICP), cerebral perfusion pressure (CerPP) and coronary perfusion pressure (CorPP).
ElevatedCPR therapy is intended to be used with a bundle of care including the EleGARDTM Patient Positioning System, active compression-decompression and/or mechanical CPR devices and an impedance threshold device (ITD) to help regulate the intrathoracic pressure while CPR is being performed.
March 18, 2019
FOR IMMEDIATE RELEASE Date: March 15, 2019 Contact: Lisa Owens, 210-601-6647, firstname.lastname@example.org EleGARD™ Patient Positioning System by AdvancedCPR Solutions™ Released for Human Use; Selected Agencies to Start Deploying April